ID   SPIN1_HUMAN             Reviewed;         262 AA.
AC   Q9Y657; A8K0X6; B3KRQ4; Q7KZJ8; Q9GZT2; Q9H0N7;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 3.
DT   07-APR-2021, entry version 161.
DE   RecName: Full=Spindlin-1;
DE   AltName: Full=Ovarian cancer-related protein;
DE   AltName: Full=Spindlin1;
GN   Name=SPIN1; Synonyms=OCR, SPIN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Pituitary;
RA   Peng Y., Song H., Dai M., Huang Q., Mao Y., Zhang Q., Mao M., Fu G.,
RA   Luo M., Chen J., Hu R.;
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhang H.L., Yu L., Wang X., Chen Z., Tu Q., Chen J.Q., Ding J.B., Gao J.,
RA   Zhao S.Y.;
RT   "Cloning, characterization and mapping of human SPIN to human chromosome
RT   9q22.1-22.3.";
RL   Chin. Sci. Bull. 45:909-914(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=16098913; DOI=10.1016/j.bbrc.2005.07.087;
RA   Gao Y., Yue W., Zhang P., Li L., Xie X., Yuan H., Chen L., Liu D., Yan F.,
RA   Pei X.;
RT   "Spindlin1, a novel nuclear protein with a role in the transformation of
RT   NIH3T3 cells.";
RL   Biochem. Biophys. Res. Commun. 335:343-350(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal kidney;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala, Hippocampus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-225.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124 AND SER-199, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF PHE-141 AND TYR-170.
RX   PubMed=21960006; DOI=10.1038/embor.2011.184;
RA   Wang W., Chen Z., Mao Z., Zhang H., Ding X., Chen S., Zhang X., Xu R.,
RA   Zhu B.;
RT   "Nucleolar protein Spindlin1 recognizes H3K4 methylation and stimulates the
RT   expression of rRNA genes.";
RL   EMBO Rep. 12:1160-1166(2011).
RN   [14]
RP   FUNCTION, INTERACTION WITH TCF7L2, PHOSPHORYLATION AT SER-109 AND SER-124,
RP   MUTAGENESIS OF SER-109 AND SER-124, AND TISSUE SPECIFICITY.
RX   PubMed=22258766; DOI=10.1158/1541-7786.mcr-11-0440;
RA   Wang J.X., Zeng Q., Chen L., Du J.C., Yan X.L., Yuan H.F., Zhai C.,
RA   Zhou J.N., Jia Y.L., Yue W., Pei X.T.;
RT   "SPINDLIN1 promotes cancer cell proliferation through activation of
RT   WNT/TCF-4 signaling.";
RL   Mol. Cancer Res. 10:326-335(2012).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124 AND SER-199, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION, INTERACTION WITH TCF7L2 AND C11ORF84/SPINDOC, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=29061846; DOI=10.1074/jbc.m117.814913;
RA   Bae N., Gao M., Li X., Premkumar T., Sbardella G., Chen J., Bedford M.T.;
RT   "A transcriptional coregulator, SPIN-DOC, attenuates the coactivator
RT   activity of Spindlin1.";
RL   J. Biol. Chem. 292:20808-20817(2017).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-7; LYS-28 AND LYS-44, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 26-262 IN COMPLEX WITH PHOSPHATE
RP   IONS, DNA-BINDING, SUBUNIT, AND DOMAINS TUDOR-LIKE.
RX   PubMed=17082182; DOI=10.1074/jbc.m604029200;
RA   Zhao Q., Qin L., Jiang F., Wu B., Yue W., Xu F., Rong Z., Yuan H., Xie X.,
RA   Gao Y., Bai C., Bartlam M., Pei X., Rao Z.;
RT   "Structure of human spindlin1. Tandem tudor-like domains for cell cycle
RT   regulation.";
RL   J. Biol. Chem. 282:647-656(2007).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 27-262 IN COMPLEX WITH METHYLATED
RP   HISTONE H3, AND MUTAGENESIS OF ASP-184 AND ASP-189.
RX   PubMed=23077255; DOI=10.1073/pnas.1208517109;
RA   Yang N., Wang W., Wang Y., Wang M., Zhao Q., Rao Z., Zhu B., Xu R.M.;
RT   "Distinct mode of methylated lysine-4 of histone H3 recognition by tandem
RT   tudor-like domains of Spindlin1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:17954-17959(2012).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 50-262 IN COMPLEX WITH METHYLATED
RP   HISTONE H3, FUNCTION, INTERACTION WITH TCF7L2, AND MUTAGENESIS OF TRP-72;
RP   TYR-98; PHE-141; GLU-142; TYR-170; TYR-177; ASP-184 AND PHE-251.
RX   PubMed=24589551; DOI=10.1101/gad.233239.113;
RA   Su X., Zhu G., Ding X., Lee S.Y., Dou Y., Zhu B., Wu W., Li H.;
RT   "Molecular basis underlying histone H3 lysine-arginine methylation pattern
RT   readout by Spin/Ssty repeats of Spindlin1.";
RL   Genes Dev. 28:622-636(2014).
CC   -!- FUNCTION: Chromatin reader that specifically recognizes and binds
CC       histone H3 both trimethylated at 'Lys-4' and asymmetrically
CC       dimethylated at 'Arg-8' (H3K4me3 and H3R8me2a) and acts as an activator
CC       of Wnt signaling pathway downstream of PRMT2. In case of cancer,
CC       promotes cell cancer proliferation via activation of the Wnt signaling
CC       pathway (PubMed:24589551). Overexpression induces metaphase arrest and
CC       chromosomal instability. Localizes to active rDNA loci and promotes the
CC       expression of rRNA genes (PubMed:21960006). May play a role in cell-
CC       cycle regulation during the transition from gamete to embryo. Involved
CC       in oocyte meiotic resumption, a process that takes place before
CC       ovulation to resume meiosis of oocytes blocked in prophase I: may act
CC       by regulating maternal transcripts to control meiotic resumption.
CC       {ECO:0000269|PubMed:21960006, ECO:0000269|PubMed:22258766,
CC       ECO:0000269|PubMed:24589551, ECO:0000269|PubMed:29061846}.
CC   -!- SUBUNIT: Homodimer; may form higher-order oligomers (PubMed:17082182).
CC       Interacts with TCF7L2/TCF4; the interaction is direct (PubMed:22258766,
CC       PubMed:24589551, PubMed:29061846). Interacts with HABP4 and SERBP1 (By
CC       similarity). Interacts with C11orf84/SPINDOC (PubMed:29061846).
CC       {ECO:0000250|UniProtKB:Q61142, ECO:0000269|PubMed:17082182,
CC       ECO:0000269|PubMed:22258766, ECO:0000269|PubMed:23077255,
CC       ECO:0000269|PubMed:24589551, ECO:0000269|PubMed:29061846}.
CC   -!- INTERACTION:
CC       Q9Y657; P04792: HSPB1; NbExp=2; IntAct=EBI-727129, EBI-352682;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16098913,
CC       ECO:0000269|PubMed:29061846}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:21960006}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in ovarian cancer tissues.
CC       {ECO:0000269|PubMed:22258766}.
CC   -!- DOMAIN: The 3 tudor-like domains (also named Spin/Ssty repeats)
CC       specifically recognize and bind methylated histones (PubMed:23077255,
CC       PubMed:24589551). H3K4me3 and H3R8me2a are recognized by tudor-like
CC       domains 2 and 1, respectively (PubMed:24589551).
CC       {ECO:0000269|PubMed:17082182, ECO:0000269|PubMed:23077255,
CC       ECO:0000269|PubMed:24589551}.
CC   -!- PTM: Phosphorylated during oocyte meiotic maturation.
CC       {ECO:0000250|UniProtKB:Q61142}.
CC   -!- SIMILARITY: Belongs to the SPIN/STSY family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD43035.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAG38112.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAG48367.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAB66653.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAG38515.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF106682; AAD43035.1; ALT_FRAME; mRNA.
DR   EMBL; AF087864; AAG48367.1; ALT_INIT; mRNA.
DR   EMBL; AF317228; AAG38112.1; ALT_INIT; mRNA.
DR   EMBL; AL136719; CAB66653.1; ALT_SEQ; mRNA.
DR   EMBL; BT007314; AAP35978.1; -; mRNA.
DR   EMBL; AK092017; BAG52466.1; -; mRNA.
DR   EMBL; AK289691; BAF82380.1; -; mRNA.
DR   EMBL; AK290009; BAF82698.1; -; mRNA.
DR   EMBL; AK315854; BAF98745.1; -; mRNA.
DR   EMBL; AL353748; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471089; EAW62753.1; -; Genomic_DNA.
DR   EMBL; BC013571; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC114515; AAI14516.1; -; mRNA.
DR   EMBL; BC114565; AAI14566.1; -; mRNA.
DR   EMBL; CR533484; CAG38515.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS43843.1; -.
DR   RefSeq; NP_006708.2; NM_006717.2.
DR   PDB; 2NS2; X-ray; 2.20 A; A/B=26-262.
DR   PDB; 4H75; X-ray; 2.10 A; A=27-262.
DR   PDB; 4MZF; X-ray; 2.10 A; B=50-262.
DR   PDB; 4MZG; X-ray; 1.70 A; B/D=50-262.
DR   PDB; 4MZH; X-ray; 2.20 A; A=50-262.
DR   PDB; 5JSG; X-ray; 2.50 A; A/B=50-262.
DR   PDB; 5JSJ; X-ray; 2.35 A; A/B=50-262.
DR   PDB; 5Y5W; X-ray; 3.30 A; A/B/C/D=51-262.
DR   PDB; 6I8B; X-ray; 1.76 A; B/E=48-262.
DR   PDB; 6I8L; X-ray; 1.58 A; B=48-262.
DR   PDB; 6I8Y; X-ray; 1.52 A; A=48-262.
DR   PDB; 6QPL; X-ray; 1.60 A; B=48-262.
DR   PDB; 7BQZ; X-ray; 3.10 A; A/C/E/G=45-262.
DR   PDB; 7BU9; X-ray; 3.50 A; A/C/E/G=45-262.
DR   PDB; 7CNA; X-ray; 1.60 A; A/D=51-262.
DR   PDBsum; 2NS2; -.
DR   PDBsum; 4H75; -.
DR   PDBsum; 4MZF; -.
DR   PDBsum; 4MZG; -.
DR   PDBsum; 4MZH; -.
DR   PDBsum; 5JSG; -.
DR   PDBsum; 5JSJ; -.
DR   PDBsum; 5Y5W; -.
DR   PDBsum; 6I8B; -.
DR   PDBsum; 6I8L; -.
DR   PDBsum; 6I8Y; -.
DR   PDBsum; 6QPL; -.
DR   PDBsum; 7BQZ; -.
DR   PDBsum; 7BU9; -.
DR   PDBsum; 7CNA; -.
DR   SMR; Q9Y657; -.
DR   BioGRID; 116130; 56.
DR   DIP; DIP-40062N; -.
DR   IntAct; Q9Y657; 28.
DR   MINT; Q9Y657; -.
DR   STRING; 9606.ENSP00000365019; -.
DR   iPTMnet; Q9Y657; -.
DR   PhosphoSitePlus; Q9Y657; -.
DR   BioMuta; SPIN1; -.
DR   DMDM; 93141317; -.
DR   EPD; Q9Y657; -.
DR   jPOST; Q9Y657; -.
DR   MassIVE; Q9Y657; -.
DR   MaxQB; Q9Y657; -.
DR   PaxDb; Q9Y657; -.
DR   PeptideAtlas; Q9Y657; -.
DR   PRIDE; Q9Y657; -.
DR   ProteomicsDB; 86603; -.
DR   Antibodypedia; 6817; 197 antibodies.
DR   Ensembl; ENST00000375859; ENSP00000365019; ENSG00000106723.
DR   GeneID; 10927; -.
DR   KEGG; hsa:10927; -.
DR   UCSC; uc004apy.4; human.
DR   CTD; 10927; -.
DR   DisGeNET; 10927; -.
DR   GeneCards; SPIN1; -.
DR   HGNC; HGNC:11243; SPIN1.
DR   HPA; ENSG00000106723; Low tissue specificity.
DR   MIM; 609936; gene.
DR   neXtProt; NX_Q9Y657; -.
DR   OpenTargets; ENSG00000106723; -.
DR   PharmGKB; PA162404504; -.
DR   VEuPathDB; HostDB:ENSG00000106723.16; -.
DR   eggNOG; ENOG502QRYD; Eukaryota.
DR   GeneTree; ENSGT00950000182925; -.
DR   HOGENOM; CLU_068595_0_0_1; -.
DR   InParanoid; Q9Y657; -.
DR   OMA; MKSTPGH; -.
DR   OrthoDB; 1027563at2759; -.
DR   PhylomeDB; Q9Y657; -.
DR   TreeFam; TF332665; -.
DR   PathwayCommons; Q9Y657; -.
DR   BioGRID-ORCS; 10927; 6 hits in 1003 CRISPR screens.
DR   ChiTaRS; SPIN1; human.
DR   EvolutionaryTrace; Q9Y657; -.
DR   GeneWiki; SPIN1; -.
DR   GenomeRNAi; 10927; -.
DR   Pharos; Q9Y657; Tbio.
DR   PRO; PR:Q9Y657; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9Y657; protein.
DR   Bgee; ENSG00000106723; Expressed in female gonad and 241 other tissues.
DR   ExpressionAtlas; Q9Y657; baseline and differential.
DR   Genevisible; Q9Y657; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0035064; F:methylated histone binding; IDA:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0007276; P:gamete generation; IEA:InterPro.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0009303; P:rRNA transcription; IDA:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 2.80.10.70; -; 1.
DR   IDEAL; IID00591; -.
DR   InterPro; IPR003671; SPIN/Ssty.
DR   InterPro; IPR042567; SPIN/Ssty_sf.
DR   InterPro; IPR029565; Spindlin-1.
DR   PANTHER; PTHR10405; PTHR10405; 1.
DR   PANTHER; PTHR10405:SF15; PTHR10405:SF15; 1.
DR   Pfam; PF02513; Spin-Ssty; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cell cycle; Chromatin regulator;
KW   Developmental protein; Isopeptide bond; Meiosis; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Ubl conjugation; Wnt signaling pathway.
FT   CHAIN           1..262
FT                   /note="Spindlin-1"
FT                   /id="PRO_0000181367"
FT   REGION          53..116
FT                   /note="Tudor-like domain 1"
FT   REGION          93..98
FT                   /note="Histone H3K4me3 and H3R8me2a binding"
FT   REGION          132..193
FT                   /note="Tudor-like domain 2"
FT   REGION          142
FT                   /note="Histone H3K4me3 and H3R8me2a binding"
FT   REGION          213..262
FT                   /note="Tudor-like domain 3"
FT   REGION          250..252
FT                   /note="Histone H3K4me3 and H3R8me2a binding"
FT   SITE            173
FT                   /note="Histone H3K4me3 and H3R8me2a binding"
FT   SITE            180
FT                   /note="Histone H3K4me3 and H3R8me2a binding"
FT   SITE            184
FT                   /note="Histone H3K4me3 and H3R8me2a binding"
FT   MOD_RES         44
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q61142"
FT   MOD_RES         109
FT                   /note="Phosphoserine; by AURKA"
FT                   /evidence="ECO:0000269|PubMed:22258766"
FT   MOD_RES         124
FT                   /note="Phosphoserine; by AURKA"
FT                   /evidence="ECO:0000269|PubMed:22258766,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        28
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        44
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         221
FT                   /note="A -> P (in dbSNP:rs34794905)"
FT                   /id="VAR_053690"
FT   MUTAGEN         72
FT                   /note="W->A,R: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a and impaired ability to activate the Wnt signaling
FT                   pathway."
FT                   /evidence="ECO:0000269|PubMed:24589551"
FT   MUTAGEN         98
FT                   /note="Y->R: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a and impaired ability to activate the Wnt signaling
FT                   pathway."
FT                   /evidence="ECO:0000269|PubMed:24589551"
FT   MUTAGEN         109
FT                   /note="S->A: Impaired phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:22258766"
FT   MUTAGEN         124
FT                   /note="S->A: Impaired phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:22258766"
FT   MUTAGEN         141
FT                   /note="F->A: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a and impaired ability to activate the Wnt signaling
FT                   pathway. Impaired ability to activate expression of pre-
FT                   rRNA."
FT                   /evidence="ECO:0000269|PubMed:21960006,
FT                   ECO:0000269|PubMed:24589551"
FT   MUTAGEN         142
FT                   /note="E->A: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a."
FT                   /evidence="ECO:0000269|PubMed:24589551"
FT   MUTAGEN         170
FT                   /note="Y->A: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a and impaired ability to activate the Wnt signaling
FT                   pathway. Impaired ability to activate expression of pre-
FT                   rRNA."
FT                   /evidence="ECO:0000269|PubMed:21960006,
FT                   ECO:0000269|PubMed:24589551"
FT   MUTAGEN         177
FT                   /note="Y->A: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a."
FT                   /evidence="ECO:0000269|PubMed:24589551"
FT   MUTAGEN         184
FT                   /note="D->A,R: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a."
FT                   /evidence="ECO:0000269|PubMed:23077255,
FT                   ECO:0000269|PubMed:24589551"
FT   MUTAGEN         189
FT                   /note="D->A,R: Impaired binding to histone H3K4me3."
FT                   /evidence="ECO:0000269|PubMed:23077255"
FT   MUTAGEN         251
FT                   /note="F->R: Impaired binding to histone H3K4me3 and
FT                   H3R8me2a and impaired ability to activate the Wnt signaling
FT                   pathway."
FT                   /evidence="ECO:0000269|PubMed:24589551"
FT   CONFLICT        49
FT                   /note="P -> S (in Ref. 6; BAG52466)"
FT                   /evidence="ECO:0000305"
FT   STRAND          57..62
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          65..67
FT                   /evidence="ECO:0007744|PDB:4MZH"
FT   STRAND          70..79
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          86..91
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          98..101
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   TURN            102..104
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          108..113
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          117..119
FT                   /evidence="ECO:0007744|PDB:6I8B"
FT   HELIX           126..129
FT                   /evidence="ECO:0007744|PDB:5Y5W"
FT   HELIX           130..132
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          136..142
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          144..146
FT                   /evidence="ECO:0007744|PDB:2NS2"
FT   STRAND          148..158
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          160..162
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          166..170
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          173..179
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   HELIX           181..186
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          190..192
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          217..220
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   TURN            223..225
FT                   /evidence="ECO:0007744|PDB:4H75"
FT   STRAND          228..235
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          237..239
FT                   /evidence="ECO:0007744|PDB:4H75"
FT   STRAND          242..247
FT                   /evidence="ECO:0007744|PDB:6I8Y"
FT   STRAND          254..257
FT                   /evidence="ECO:0007744|PDB:6I8Y"
SQ   SEQUENCE   262 AA;  29601 MW;  49F86CBCC7A0AA01 CRC64;
     MKTPFGKTPG QRSRADAGHA GVSANMMKKR TSHKKHRSSV GPSKPVSQPR RNIVGCRIQH
     GWKEGNGPVT QWKGTVLDQV PVNPSLYLIK YDGFDCVYGL ELNKDERVSA LEVLPDRVAT
     SRISDAHLAD TMIGKAVEHM FETEDGSKDE WRGMVLARAP VMNTWFYITY EKDPVLYMYQ
     LLDDYKEGDL RIMPDSNDSP PAEREPGEVV DSLVGKQVEY AKEDGSKRTG MVIHQVEAKP
     SVYFIKFDDD FHIYVYDLVK TS
//
